A novel topical combination of minoxidil and spironolactone for androgenetic alopecia: Clinical, histopathological, and physicochemical study
- 15 December 2020
- journal article
- research article
- Published by Wiley in Dermatologic Therapy
- Vol. 34 (1) , e14678
Abstract
Topical minoxidil 5% are effective in androgenetic alopecia (AGA). Spironolactone acts as an androgen antagonist by competitively blocking androgen receptors. Studying the effect of topical minoxidil 5% gel and spironolactone gel 1% in management of AGA. The study includes 60 patients diagnosed as AGA; (group I): treated with topical minoxidil gel 5%, (group II): with topical spironolactone gel 1% and group (III) treated with combined minoxidil 5% and spironolactone 1% gel. All patients were followed up monthly throughout the treatment period. Scalp biopsy was taken before and after 12 months. In group I, the clinical response was in 90% of patients with variable degrees in improvement, in group II, the clinical response was in 80% of patients, meanwhile, in group III the clinical response was in all patients (100%). Histopathological examination of skin biopsy after treatment revealed significant increase in anagen hair on the other hand, both telogen and vellus hair was significantly decreased meanwhile, the T/V ratio was significantly increased. The results of this work revealed that topical minoxidil gel 5% and topical spironolactone gel 1% were effective in treatment of AGA, while the combination of two agents was better in treatment.Keywords
This publication has 22 references indexed in Scilit:
- A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in womenJournal of the American Academy of Dermatology, 2011
- Role of genetics and sex steroid hormones in male androgenetic alopecia and female pattern hair loss: An update of what we now knowAustralasian Journal of Dermatology, 2011
- S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescentsBritish Journal of Dermatology, 2010
- Androgenetic alopecia in males: a histopathological and ultrastructural studyJournal of Cosmetic Dermatology, 2009
- Treatment of female pattern hair loss with a combination of spironolactone and minoxidilAustralasian Journal of Dermatology, 2007
- Efficacy of 5% Minoxidil versus Combined 5% Minoxidil and 0.01% Tretinoin for Male Pattern Hair LossAmerican Journal of Clinical Dermatology, 2007
- Alopecia areata investigational assessment guidelines–Part IIJournal of the American Academy of Dermatology, 2004
- Androgens and alopeciaMolecular and Cellular Endocrinology, 2002
- ANTIANDROGEN THERAPY IN DERMATOLOGYInternational Journal of Dermatology, 1996
- Psychological effects of androgenetic alopecia on women: Comparisons with balding men and with female control subjectsJournal of the American Academy of Dermatology, 1993